Time to discontinuation of non-vitamin k antagonist oral anticoagulants in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Garcia Rodriguez, L. A. [1 ]
Vora, P. [2 ]
Brobert, G. [3 ]
Lenz, Y. [2 ]
Ruigomez, A. [1 ]
机构：
[1] Spanish Res Ctr Pharmacoepidemol CEIFE, Madrid, Spain
[2] Bayer AG, Epidemiol, Berlin, Germany
[3] Bayer AB, Epidemiol, Solna, Sweden
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4754
引用
收藏
页码：2958 / 2958
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
    Kim, Hyue Mee
    Choi, Eue-Keun
    Park, Chan Soon
    Cha, Myung-Jin
    Lee, Seo-Young
    Kwon, Joon-Myung
    Oh, Seil
    [J]. PLOS ONE, 2019, 14 (03):
  • [2] Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
    Basaran, Ozcan
    Dogan, Volkan
    Sahin, Cem
    Biteker, Murat
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 357 - 357
  • [3] Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life
    Giustozzi, Michela
    Vedovati, Maria Cristina
    Verdecchia, Paolo
    Pierpaoli, Lucia
    Verso, Melina
    Conti, Serenella
    Cianella, Federica
    Marchesini, Emanuela
    Filippucci, Esmeralda
    Agnelli, Giancarlo
    Becattini, Cecilia
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 42 - 46
  • [4] Non-vitamin K antagonist oral anticoagulant discontinuation in non-valvular atrial fibrillation patients (ASPECT-NOAC)
    Asilturk, E.
    Tulmac, M.
    Badak, O.
    Onal, T.
    Aras, D.
    Aciksari, G.
    Alper, A. T.
    Celik, A.
    Katicibasi, T.
    Ozdogan, O.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 576 - 576
  • [5] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients With Non-Valvular Atrial Fibrillation and Diabetes
    Deitelzweig, Steve
    Keshishian, Allison
    Li Xiaoyan
    Dhamane, Amol
    Luo Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan Xianying
    Nadkarni, Anagha
    Di Fusco, Manuela
    Garcia, Alessandra B.
    Yuce, Huseyin
    Lip, Gregory Y.
    [J]. CIRCULATION, 2018, 138
  • [6] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation
    Yunchai Lin
    Hongping Xiong
    Jinzi Su
    Jinxiu Lin
    Qiang Zhou
    Meihua Lin
    Wenxiang Zhao
    Feng Peng
    [J]. Heart and Vessels, 2022, 37 : 1224 - 1231
  • [7] Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
    Yasaka, Masahiro
    Lip, Gregory Y. H.
    [J]. CIRCULATION JOURNAL, 2014, 78 (10) : 2367 - 2372
  • [8] Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Wu, Shanshan
    Xie, Shuo
    Xu, Yingjie
    Que, Dongdong
    Yau, Tung On
    Wang, Lizi
    Huang, Yuanping
    [J]. JOURNAL OF CLINICAL NURSING, 2019, 28 (9-10) : 1839 - 1846
  • [9] Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
    Garcia Rodriguez, Luis Alberto
    Martin-Perez, Mar
    Vora, Pareen
    Roberts, Luke
    Balabanova, Yanina
    Brobert, Gunnar
    Fatoba, Samuel
    Suzart-Woischnik, Kiliana
    Schaefer, Bernhard
    Ruigomez, Ana
    [J]. BMJ OPEN, 2019, 9 (09):
  • [10] THE EFFECT OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS ON RENAL OUTCOMES IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION.
    Deeprom, Siwaporn
    Chirananthavat, Thanit
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1028 - 1028
12345